iPeer2Peer Program for Adolescents With Inflammatory Bowel Disease

The iPeer2Peer program matches teens with Inflammatory Bowel Disease (IBD) with an older mentor who has learned to manage their IBD well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer program and those in the control group (no mentor).

Study Overview

• Status: Completed
• Conditions: Inflammatory Bowel Diseases
• Intervention / Treatment: Behavioral: iPeer2Peer program; Other: Waitlist control

Detailed Description

The iPeer2Peer program matches teens with Inflammatory Bowel Disease (IBD) with an older mentor who has learned to manage their IBD well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer program and those in the control group (no mentor).

The proposed trial aims to examine the impact of the iPeer2Peer program on self-management skills of youth with IBD (mentees) as well as health outcomes of peer mentors in the program. This innovative program leverages the Internet, commonly used by youth, to improve access and acceptability of self-management interventions while fostering social engagement in youth with IBD, thereby potentially improving HRQL.

• Study Type: Interventional
• Enrollment (Actual): 150
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Sara Ahola Kohut, PhD; Phone Number: 416-813-8106; Email: sara.aholakohut@sickkids.ca
• Study Contact Backup: Name: Natalie Weiser, MA; Phone Number: 301962 416-813-7654; Email: natalie.weiser@sickkids.ca

Study Locations

• Canada
  • British Columbia
    • Vancouver, British Columbia, Canada, V6H 3N1
      • BC Children's Hospital
  • Nova Scotia
    • Halifax, Nova Scotia, Canada, B3K 6R8
      • The IWK Health Centre
  • Ontario
    • Ottawa, Ontario, Canada, K1H 8L1
      • Children's Hospital of Eastern Ontario
    • Toronto, Ontario, Canada, M5G 1X8
      • The Hospital for Sick Children

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 12 years to 18 years (Child, Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• males and females 12-18 years old,
• gastroenterologist-diagnosed IBD,
• able to speak and read English,
• access to a computer, smartphone or tablet capable of using free Skype software (note: participants who do not have adequate Internet access will be provided with portable Internet devices),
• willing and able to complete online measures.

Exclusion Criteria:

• significant cognitive impairments or
• severe co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQL assessment (e.g., psychosis, active suicidal ideation),
• participating in other peer support or self-management interventions

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: iPeer2Peer Mentorship; 10 sessions of 20-30 minute Skype video calls conducted over 5-12 weeks.	Behavioral: iPeer2Peer program; In addition to standard care, youth in the experimental group will receive the iPeer2Peer Program. The iPeer2Peer program is a peer mentorship program that will provide modeling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with IBD aged 18-25 years) who have learned to function successfully with their disease. Mentors will encourage youth to develop and engage in disease self-management skills and provide social support.
Active Comparator: Waitlist Control Group; The control group will receive standard care but without the iPeer2Peer program.	Other: Waitlist control; The control group will receive standard care but without the iPeer2Peer Program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
TRANSITION-Q (measuring change)	14-item scale that measures self-management skills in health and healthcare in adolescents with chronic health conditions.	Baseline; up to 12 weeks after baseline; 6 months post program

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Disease Activity Survey (measuring change)	21-item survey to measure disease activity and alternative resources therapies used by patients. The scale used in this study is from the Brief Pain Inventory. The scale ranges from 0 to 10 and the higher the value the worse the outcome.	Baseline; up to 12 weeks after baseline; 6 months post program
IBD Self-efficacy Scale for Adolescents and Young Adults (measuring change)	13-item disease-specific scale to assess SE toward disease management for adolescents and young adults with IBD. Scale scores range from 1 to 5. The higher value represents a better outcome.	Baseline; up to 12 weeks after baseline; 6 months post program
Brief Resiliency Scale (measuring change)	6-item measure that assesses an individual's ability to bounce back or recover from stress. The total range is a score from 6 to 30. A higher final score represents a better outcome.	Baseline; up to 12 weeks after baseline; 6 months post program
Revised Child Anxiety and Depression Scale (measuring change)	25-item self-report measure of anxiety and depression characteristics. Measure includes a score for total anxiety, total depression, and total anxiety and depression. The scale ranges from a minimum score of 0 to a maximum score of 3. A higher score represents a worse outcome.	Baseline; up to 12 weeks after baseline; 6 months post program
PROMIS Pediatric Item Bank v.1.0 - Peer Relationships - Short Form 8a	15-item measure of social health via social function and overall sociability. The scale ranges from value of 0 to 4. The higher the value the better the outcome.	Baseline; up to 12 weeks after baseline; 6 months post program
IMPACT-III: A Quality of Life Questionnaire for Children with Inflammatory Bowel Disease (measuring change)	35-item quality of life measure specific to pediatric IBD populations. Domain scores include: bowel symptoms, systemic symptoms, emotional functioning, social functioning, body image, and treatment/interventions.	Baseline; up to 12 weeks after baseline; 6 months post program
Assessment of Quality if Life (AQoL-6D) (measuring change)	20-item self-report measure for six separately scored dimensions and a simple global "utility" score. The scores range from 1 to 5. The higher the score the worse the outcome.	Baseline; up to 12 weeks after baseline; 6 months post program
Health Services Use and Out-of-Pocket Expense Diary (measuring change)	53-item self-report measure to assess health service use and out of pocket expenses	Baseline; up to 12 weeks after baseline; 6 months post program
Mentor Behavior Scale (measuring change)	15-item measure of 4 factors that affect mentor quality: structure, engagement, autonomy support, and competency support. The scale ranges in values from 1 to 5. The higher the score the higher the mentor is rated.	post-intervention (approximately following 12 weeks of calls)
PROMIS Adult Profile v2.0 (measuring change)	For mentors only. 29-item collection of short forms from 7 health domains: depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and ability to participate in social roles and activities. The scale is scored from 1 to 5. The higher the score the worse the outcome.	At beginning of study and at end of study (approximately 3 years later)
PROMIS Satisfaction with Social Roles and Activities (measuring change)	For mentors only. 44-item questionnaire that measures satisfaction with one's social functioning (e.g., ability to participate in social roles and activities, and satisfaction with social roles and responsibilities) and social relationships (e.g., companionship, emotional, informational and instrumental support, and social isolation) The scale ranges from scores 1 to 5. The higher the score the better the outcome.	At beginning of study and at end of study (approximately 3 years later)
Chronic Disease Self-Efficacy scale (measuring change)	For mentors only. 33-item measure with 10 subscales. The scale ranges from scores of 1 to 10. The higher the score the better the outcome. subscales are conceptually divided into 3 types of self-efficacy: 1). ability to self-management behaviors, 2) ability to manage disease in general, and 3) ability to achieve outcomes.	At beginning of study and at end of study (approximately 3 years later)
Mentor Interaction form	Record of interactions with mentees	Following completion of each mentee's calls (approximately following 12 weeks of calls)

Collaborators and Investigators

• Sponsor: The Hospital for Sick Children

Study record dates

Study Major Dates

• Study Start (Actual): May 17, 2018
• Primary Completion (Actual): March 16, 2022
• Study Completion (Actual): March 16, 2022

Study Registration Dates

• First Submitted: August 9, 2018
• First Submitted That Met QC Criteria: August 9, 2018
• First Posted (Actual): August 14, 2018

Study Record Updates

• Last Update Posted (Actual): April 12, 2023
• Last Update Submitted That Met QC Criteria: April 11, 2023
• Last Verified: April 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Gastrointestinal Diseases; Gastroenteritis; Inflammatory Bowel Diseases; Intestinal Diseases
• Other Study ID Numbers: 1000058684

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No